# Optimal Timing of Endoscopic Intervention in the Treatment of Chronic Pancreatitis.

> **NCT05270434** · NA · COMPLETED · sponsor: **Changhai Hospital** · enrollment: 220 (actual)

## Conditions studied

- Pancreatitis, Chronic

## Interventions

- **PROCEDURE:** time interval between ESWL and ERCP is 12h
- **PROCEDURE:** time interval between ESWL and ERCP is greater than 12h
- **DRUG:** morphine, buprenorphine, pethidine, tramaldol, metamizole and acetylsalicylacid (Analgesics)

## Key facts

- **NCT ID:** NCT05270434
- **Lead sponsor:** Changhai Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-03-12
- **Primary completion:** 2025-10-18
- **Final completion:** 2025-10-20
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2025-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05270434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05270434, "Optimal Timing of Endoscopic Intervention in the Treatment of Chronic Pancreatitis.". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05270434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*